Systemic steroids may not reduce hospital length of stay in acute orbital cellulitis: Study
Corticosteroid treatment is not associated with reduced hospital length of stay (LOS) for children hospitalized for acute orbital cellulitis, according to a recent study published in Pediatrics.
Standard treatment of children hospitalized for acute orbital cellulitis includes systemic antibiotics. Recent data from single-centre studies suggest the addition of systemic corticosteroids may hasten clinical improvement and reduce hospital length of stay (LOS).
A group of researchers conducted a study to investigate the potential relationship between corticosteroid exposure and duration of hospitalization for pediatric orbital cellulitis.
Using Pediatric Health Information System registry data from 51 children's facilities, we performed a retrospective cohort study of children hospitalized for orbital cellulitis <18 years of age from 2007 to 2018. The primary study outcome was hospital length of stay (LOS). Secondary outcomes included frequency of surgical interventions, PICU admission, and 30-day related-cause readmission.
The results of the study are as follows:
- Of the 5645 children included in the study, 1347 (24%) were prescribed corticosteroids within two days of admission.
- Corticosteroid prescription was not associated with hospital length of stay (LOS) in analyses adjusted for age; the presence of meningitis, abscess, or vision issues; and operative episode and PICU admission within 2 days
- Corticosteroid exposure was associated with operative episodes after 2 days of hospitalization and 30-day readmission among patients with a primary diagnosis of orbital cellulitis.
Therefore, the researchers concluded that in this database query, we were not able to detect a reduction in hospital length of stay (LOS) associated with corticosteroid exposure during hospitalization for orbital cellulitis. Corticosteroid prescription was associated with PICU admission and operative episodes after 2 days of hospitalization. Before the adoption of routine corticosteroid use, prospective, randomized control trials are needed.
Reference:
A study named, "Corticosteroids for Acute Orbital Cellulitis"by Maria Anna Leszczynska et al. published in the Pediatrics.
DOI: https://doi.org/10.1542/peds.2021-050677
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.